Broker research reports for stocks which have been downgraded by brokers. Both recommendation downgrades,
as well as share price target downgrades are available for companies in Industry - Industrial Machinery.
Broker Research reports: latest Downgrades
for Industry - Industrial Machinery
Q2FY26 performance: The Anup engineering came out with decent set of Q2FY26 results. Revenue grew 20% YoY to 232 crore, EBITDA grew 19% YoY to 51 crore and PAT declined by 1.5% YoY to 32 crore due to normalisation of the effective tax rate. EBITDA margins down by 27 bps to 22.02% whereas, PAT margins down 304 bps to 13.8%. Company received order inflows of ~197 crore and has an unexecuted order book of 568 crore as of H1FY26. Order wins to get converted from the bid pipeline for growth visibility: Current orderbook 568 crore ensures solid revenue booking for FY26E....
Cummins India (KKC) delivered robust performance in Q2FY26 which surpassed our estimates. Revenue, EBITDA and PAT for the quarter was higher by 26%, 44% and 39% YoY on consolidated basis. Demand continues to be healthy emanating from verticals such as Quick Commerce, Mission Critical Infrastructure, Real Estate and Data Centres for the PowerGen segment. KKC also clocked in healthy gross margin of ~37% for the quarter. This is a result of the management's assiduous efforts in reducing direct material costs, optimizing product mix and suitable pricing. Guidance is of double digit revenue...
We revise our FY26/27E EPS estimates by -37.8%/-20.6% and downgrade the stock from Buy' to Hold' amid delayed order booking and execution due to tariff related uncertainties and liquidity challenges in domestic market. The company delivered a weak quarterly performance, with revenue declining 8.4% YoY and EBITDA margin contracting 685bps YoY to 5.6%, primarily due to execution delays. Tariff-related uncertainties affected order finalization, while funding constraints among customers halted dispatches in the domestic market straining working capital of the company and elongating the execution...
Kirloskar Oil Engines Ltd. (KOEL) posted healthy financial performance in Q1FY26. Power Gen (PG) segment clocked in 15% YoY growth to come in at Rs 6.1bn owing to sales volumes returning back to normalcy and healthy growth in the HHP segment. The LHP and MHP segment which is the mainstay of KOEL witnessed volumes normalizing back to the pre CPCB IV+ period. Demand trends stay positive with infrastructure verticals such as residential and commercial realty exhibiting good demand. Demand also continues to be broad based across various infrastructure verticals. The management wants to focus actively on...
strong demand across segments. In Powergen, CPCB IV+ compliant products accounted for ~60% of domestic sales, with overall volumes reaching CPCB II drive Powergen growth. The Industrial segment maintained steady momentum, supported by strong execution and growing aftermarket services across Railways, Construction, Mining, and Compressors. New product launches and deeper market penetration further bolstered the Distribution segment. On the export front, Latin America and Europe remained primary growth drivers, although management remains cautiously optimistic amid global...
Kirloskar Oil Engines’ (KOEL) 1QFY26 result was above our expectations, driven by higher growth in the powergen segment and improved margin. Genset demand has been recovering in key segments and the B2C segment for KOEL too has now stabilized.
Cummins India (KKC)’s 4QFY25 results reflected weakness in revenue, while EBITDA margin and PAT outperformed our estimates. The company reported 6% YoY revenue growth, while EBITDA/PAT declined by 5%/7% YoY, mainly due to a high base of last year.
We revise our FY26/27 EPS estimates by -1.2%/-2.1% given the cautious export outlook amid tariff and geopolitical uncertainties. Cummins India (KKC) reported a revenue growth of 6.4% YoY, while EBITDA margin shrunk by 235bps YoY to 21.2% against a high base. The pre-buy of CPCB IV+ compliant gensets in base quarter saw a YoY decline in powergen segment. While volumes and pricing of CPCB IV+ products are expected to stabilize over the next few quarters, powergen continues to benefit from strong demand across end industries, including emerging opportunities in power backup for quick...
We revise our FY26/27E EPS estimates by -27.3%/-39.0% accounting for delayed order booking for GenX facility and slower execution of long duration engineering orders. The company reported a weak quarterly performance, with revenue declining by 15.6% YoY, while EBITDA margins contracted by 362bps YoY to 8.8%, primarily due to execution delays. Despite near-term headwinds, Praj's growth prospects in BioEnergy remain robust driven by prospective mandates for ethanol blending in petrol to 25%-30% and blending in diesel, along with co-product development opportunities with existing ethanol plants....
We met with the management of Praj Industries at a conference, where they provided insights into the progress of Praj's GenX facility and the growth prospects across its business verticals. The orders for the GenX facility are anticipated from Q1FY26 while the facility is expected to contribute peak revenue of ~Rs10-25bn per annum. Challenges persist in the CBG sector due to concerns over operational and economic viability. However, Praj remains confident in its prospects, supported by its multi-feedstock technology. The potential imposition of reciprocal tariffs by the U.S. is not expected to have a...
Cummins reported a robust Q3 revenue print; margin remains off its peak levels seen in H2FY24 (though still robust). A sequential revenue jump of 24% was largely driven by the HHP segment of the domestic power gen business (74% contribution to incremental revenue QoQ).
3M India’s EBITDA margin of 14.1% in Q3FY25 was at its lowest since the past nine quarters. We believe INR depreciation and higher freight cost impacted 3M’s margins.
Cummins India’s Q1FY25 print stood impressive (soft revenue growth, stellar margin expansion) with management commentary exuding optimism for domestic business in near term.